That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested in the Psychedelics...
Redefining how the world approaches, prevents, and heals mental health disorders.
LIVE QUOTE
Teplizumab: Can We Delay the Onset of Type 1? (DiaTribe)
Teplizumab: Can We Delay the Onset of Type 1?
Last updated: 6/7/21
By Dr. Francine...
Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.
Up as much as 417% from where we added it to the Watch List, the Company continues to report increasing revenues while...
Aphex BioCleanse (SNST) Making Serious Headlines.
Relatively quiet for most of the year. Aphex BioCleanse, our favorite Super Bug sanitizer company, made two back-to-back announcements - signaling things...
Draganfly (DFLYF) to Deploy Aerial Sanitation Drones Over NASCAR Event.
Nashville Superspeedway Selects Draganfly Drone Services for June 18-20 NASCAR Weekend
Los Angeles,...
GBT Technologies (GTCH) Aims to Power Wearable GPS Tracker for Seniors.
GOPHER | GBT TECNOLOGIES
https://youtu.be/9ovYCMHmOi8
GBT Technologies and GTX Corp. Enter into...
Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in Stem Cell and...
- Addition of leading scholar and KOL in acute respiratory distress syndrome (ARDS) to ARDS Scientific Advisory Board supports continued progress of...
Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).
Jun. 15, 2021 10:41 AM ET Citius Pharmaceuticals, Inc. (CTXR)
Summary
Adding Cyclerion Thera (CYCN) $3.75, to Biotech Stock Review Watch List.
From the Tiki Hut Fund
Cyclerion Therapeutics Inc (CYCN) | And We Have Deal, Up 30%.
LIVE...
More Great News From Citius Pharma (CTXR).
UPDATED CHART 6-15-21
Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
Latest article
Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC
Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...
GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...
Adding Allarity (ALLR) $0.70, to Watch List.
LIVE QUOTE
SHORT TERM CHART
Bargain Hunting?
Adding to the...
